ClinVar Miner

Submissions for variant NM_000059.4(BRCA2):c.1910-1_1914del

dbSNP: rs1593895760
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001013657 SCV001174272 likely pathogenic Hereditary cancer-predisposing syndrome 2019-09-19 criteria provided, single submitter clinical testing The c.1910-1_1914delGGTTTA variant results from a deletion of 6 nucleotides at positions c.1910-1 to c.1914, spanning the splice acceptor junction at the 5' end of coding exon 10 in the BRCA2 gene. Based on two different splice site prediction tools, this alteration is expected to abolish the native splice acceptor site; however experimental evidence is not currently available. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.